Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts
Authors:
- Paola FaddaPFPaola Fadda
- Lianne RobinsonLRLianne Robinson
- Walter FrattaWFWalter Fratta
- Roger G. PertweeRPRoger G. Pertwee
- Gernot RiedelGRGernot Riedel
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 168 (2) , 307-311
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cholinesterase Inhibitors Ameliorate Behavioral Deficits Induced by MK-801 in MiceNeuropsychopharmacology, 2005
- Differential effects of THC- or CBD-rich cannabis extracts on working memory in ratsNeuropharmacology, 2004
- SR 141716A prevents Δ9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in miceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2002
- Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampusNeuroscience, 2001
- Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in ratsNeuroReport, 2000
- Effect of rivastigmine on scopolamine-induced memory impairment in ratsEuropean Journal of Pharmacology, 1999
- Role of Cannabinoid Receptors in Memory StorageNeurobiology of Disease, 1998
- Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716AEuropean Journal of Pharmacology, 1998
- Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidantsProceedings of the National Academy of Sciences, 1998
- Cognitive Correlates of Long-term Cannabis Use in Costa Rican MenArchives of General Psychiatry, 1996